These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
96 related items for PubMed ID: 9923089
1. Meal-related changes in plasma CCK bioactivity in patients with chronic pancreatitis. Nakamura T, Tando Y, Yamada N, Imamura K, Ishii M, Terada A, Takebe K, Kaji A, Watanabe T, Suda T, Koide M, Otsuki M. Acta Gastroenterol Belg; 1998; 61(4):400-6. PubMed ID: 9923089 [Abstract] [Full Text] [Related]
2. [Plasma cholecystokinin level in chronic pancreatitis]. Mössner J, Back T, Regner U, Fischbach W. Z Gastroenterol; 1989 Aug; 27(8):401-5. PubMed ID: 2609704 [Abstract] [Full Text] [Related]
3. Relationship between postprandial release of CCK and PP in health and in chronic pancreatitis. Glasbrenner B, Dominguez-Muñoz JE, Nelson DK, Riepl RL, Büchler M, Malfertheiner P. Regul Pept; 1994 Feb 03; 50(1):45-52. PubMed ID: 8159806 [Abstract] [Full Text] [Related]
4. Plasma cholecystokinin levels in patients with chronic pancreatitis. Schafmayer A, Becker HD, Werner M, Fölsch UR, Creutzfeldt W. Digestion; 1985 Feb 03; 32(2):136-9. PubMed ID: 4043564 [Abstract] [Full Text] [Related]
8. Cholecystokinin secretion in patients with chronic pancreatitis and after different types of pancreatic surgery. Eddes EH, Masclee AA, Gielkens HA, Verkijk M, Vecht J, Biemond I, Lamers CB. Pancreas; 1999 Aug 03; 19(2):119-25. PubMed ID: 10438157 [Abstract] [Full Text] [Related]
9. Effect of pancreatic enzyme supplementation on postprandial plasma cholecystokinin secretion in patients with pancreatic insufficiency. Jansen JB, Jebbink MC, Mulders HJ, Lamers CB. Regul Pept; 1989 Aug 03; 25(3):333-42. PubMed ID: 2772268 [Abstract] [Full Text] [Related]
11. Determination of plasma cholecystokinin (CCK) concentrations by bioassay and radioimmunoassay in man. A critical evaluation. Höcker M, Schmidt WE, Creutzfeldt W, Choudhury AR, Nustede R, Schafmayer A, Fölsch UR. Regul Pept; 1992 Feb 18; 37(3):255-69. PubMed ID: 1557514 [Abstract] [Full Text] [Related]
12. High plasma cholecystokinin levels in patients with chronic pancreatitis having abdominal pain. Funakoshi A, Nakano I, Shinozaki H, Tateishi K, Hamaoka T, Ibayashi H. Am J Gastroenterol; 1986 Dec 18; 81(12):1174-8. PubMed ID: 3538853 [Abstract] [Full Text] [Related]
13. Plasma cholecystokinin concentrations in patients with advanced chronic pancreatitis. Cantor P, Petronijevic L, Worning H. Pancreas; 1986 Dec 18; 1(6):488-93. PubMed ID: 3562443 [Abstract] [Full Text] [Related]
14. No negative feedback regulation between plasma CCK levels and luminal tryptic activities in patients with pancreatic insufficiency. Nakamura T, Takebe K, Kudoh K, Ishii M, Imamura K, Kikuchi H, Kasai F, Tandoh Y, Yamada N, Arai Y. Int J Pancreatol; 1995 Feb 18; 17(1):29-35. PubMed ID: 8568332 [Abstract] [Full Text] [Related]
17. [Bioassay for plasma cholecystokinin bioactivity]. Sun G. Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1991 Dec 18; 13(6):417-21. PubMed ID: 1724414 [Abstract] [Full Text] [Related]
18. Orlistat reduces gallbladder emptying by inhibition of CCK release in response to a test meal. Ellrichmann M, Ritter PR, Otte JM, Schrader H, Banasch M, Brunke G, Herzig KH, Seebeck J, Schmidt WE, Schmitz F. Regul Pept; 2007 Mar 01; 139(1-3):136-40. PubMed ID: 17175037 [Abstract] [Full Text] [Related]